Cite
Cyclophosphamide-induced cardiotoxicity at conditioning for allogeneic hematopoietic stem cell transplantation would occur among the patients treated with 120 mg/kg or less.
MLA
Marumo, Atsushi, et al. “Cyclophosphamide-Induced Cardiotoxicity at Conditioning for Allogeneic Hematopoietic Stem Cell Transplantation Would Occur among the Patients Treated with 120 Mg/Kg or Less.” Asia-Pacific Journal of Clinical Oncology, vol. 18, no. 5, Oct. 2022, pp. e507–14. EBSCOhost, https://doi.org/10.1111/ajco.13674.
APA
Marumo, A., Omori, I., Tara, S., Otsuka, Y., Konuma, R., Adachi, H., Wada, A., Kishida, Y., Konishi, T., Nagata, A., Yamada, Y., Nagata, R., Noguchi, Y., Toya, T., Igarashi, A., Najima, Y., Kobayashi, T., Yamaguchi, H., Inokuchi, K., … Doki, N. (2022). Cyclophosphamide-induced cardiotoxicity at conditioning for allogeneic hematopoietic stem cell transplantation would occur among the patients treated with 120 mg/kg or less. Asia-Pacific Journal of Clinical Oncology, 18(5), e507–e514. https://doi.org/10.1111/ajco.13674
Chicago
Marumo, Atsushi, Ikuko Omori, Shuhei Tara, Yuki Otsuka, Ryosuke Konuma, Hiroto Adachi, Atsushi Wada, et al. 2022. “Cyclophosphamide-Induced Cardiotoxicity at Conditioning for Allogeneic Hematopoietic Stem Cell Transplantation Would Occur among the Patients Treated with 120 Mg/Kg or Less.” Asia-Pacific Journal of Clinical Oncology 18 (5): e507–14. doi:10.1111/ajco.13674.